During the past decade, Santa Cruz Behavioral PSC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 7 clinical trials were completed, i.e. on average, 70% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Santa Cruz Behavioral PSC" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Santa Cruz Behavioral PSC" are "Alzheimer Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Psoriasis" (2 trials), "Alzheimer´s Disease" (1 trials) and "Lewy Body Dementia" (1 trials). Many other conditions were trialed in "Santa Cruz Behavioral PSC" in a lesser frequency.

Most popular intervention types in "Santa Cruz Behavioral PSC" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Gantenerumab" (2 trials), "Lanabecestat" (2 trials), "Mirikizumab" (2 trials) and "Guselkumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Santa Cruz Behavioral PSC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Santa Cruz Behavioral PSC". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Santa Cruz Behavioral PSC, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Santa Cruz Behavioral PSC, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".